Lars Rydén

31.6k total citations · 2 hit papers
203 papers, 8.6k citations indexed

About

Lars Rydén is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Lars Rydén has authored 203 papers receiving a total of 8.6k indexed citations (citations by other indexed papers that have themselves been cited), including 93 papers in Cardiology and Cardiovascular Medicine, 31 papers in Molecular Biology and 26 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Lars Rydén's work include Cardiac pacing and defibrillation studies (24 papers), Cardiac electrophysiology and arrhythmias (22 papers) and Cardiac Imaging and Diagnostics (21 papers). Lars Rydén is often cited by papers focused on Cardiac pacing and defibrillation studies (24 papers), Cardiac electrophysiology and arrhythmias (22 papers) and Cardiac Imaging and Diagnostics (21 papers). Lars Rydén collaborates with scholars based in Sweden, United States and France. Lars Rydén's co-authors include Eberhard Standl, Barry M. Massie, John D. Horowitz, Paul W. Armstrong, John G.F. Cleland, Milton Packer, Philip A. Poole‐Wilson, Kristian Thygesen, Barry F. Uretsky and K. Malmberg and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Lars Rydén

197 papers receiving 8.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Comparative Effects of Low and High Doses of the Angiotensin-Converting Enzyme Inhibitor, Lisinopril, on Morbidity and Mortality in Chronic Heart Failure

1999 833 citations Milton Packer, Paul W. Armstrong et al. profile →
Diabetes as a cardiovascular risk factor: An overview of global trends of macro and micro vascular complications

2019 584 citations Lars Rydén et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lars Rydén Sweden	47	4.6k	1.9k	1.5k	1.1k	656	203	8.6k
Hiroshi Sato Japan	49	3.9k 0.9×	720 0.4×	2.6k 1.8×	1.6k 1.4×	875 1.3×	319	10.9k
Yong Huo China	43	3.3k 0.7×	777 0.4×	732 0.5×	1.8k 1.7×	690 1.1×	504	8.3k
Hyun‐Young Park South Korea	45	1.6k 0.4×	1.0k 0.5×	1.2k 0.8×	807 0.7×	931 1.4×	300	6.9k
Tanja Zeller Germany	48	4.0k 0.9×	707 0.4×	2.7k 1.8×	1.4k 1.3×	1.0k 1.5×	351	9.8k
Yan Zhang China	47	3.3k 0.7×	662 0.3×	1.8k 1.2×	1.1k 1.0×	576 0.9×	439	10.3k
Mark S. Segal United States	52	1.3k 0.3×	1.3k 0.7×	3.1k 2.1×	1.3k 1.2×	1.7k 2.6×	207	11.0k
Paul Sherliker United Kingdom	26	1.7k 0.4×	1.3k 0.7×	865 0.6×	2.0k 1.9×	1.1k 1.7×	54	8.6k
Paolo Chiodini Italy	55	1.7k 0.4×	2.6k 1.4×	1.9k 1.3×	1.6k 1.5×	1.3k 2.0×	250	10.4k
Salvatore Panico Italy	48	1.2k 0.3×	981 0.5×	1.5k 1.1×	801 0.7×	802 1.2×	211	7.5k
Yu Xu China	37	1.3k 0.3×	2.3k 1.2×	1.4k 1.0×	872 0.8×	1.8k 2.8×	217	7.4k

Countries citing papers authored by Lars Rydén

Since Specialization

Citations

This map shows the geographic impact of Lars Rydén's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lars Rydén with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lars Rydén more than expected).

Fields of papers citing papers by Lars Rydén

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lars Rydén. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lars Rydén. The network helps show where Lars Rydén may publish in the future.

Co-authorship network of co-authors of Lars Rydén

This figure shows the co-authorship network connecting the top 25 collaborators of Lars Rydén. A scholar is included among the top collaborators of Lars Rydén based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lars Rydén. Lars Rydén is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Makubi, Abel, Camilla Hage, Ulrik Sartipy, et al.. (2016). Heart failure in Tanzania and Sweden: Comparative characterization and prognosis in the Tanzania Heart Failure (TaHeF) study and the Swedish Heart Failure Registry (SwedeHF). International Journal of Cardiology. 220. 750–758. 12 indexed citations

Rydén, Lars. (2010). Governing a Common Sea : Environmental Policies in the Baltic Sea Region. Journal of Baltic Studies. 41(3). 408–410. 39 indexed citations

Melcher, A., et al.. (2008). Left aTrial Velocity Vector Imaging for the Detection and Quantification of Left Ventricular Diastolic Function in Type 2 Diabetes. European Journal of Heart Failure. 10(11). 1080–1087. 48 indexed citations

Komajda, Michel, Beatrix Lutiger, Hugo Madeira, et al.. (2004). Tolerability of Carvedilol and ACE-Inhibition in Mild Heart Failure. Results of CARMEN (Carvedilol ACE-Inhibitor Remodelling Mild CHF EvaluatioN). European Journal of Heart Failure. 6(4). 467–475. 55 indexed citations

Rydén, Lars, et al.. (2004). "The Baltic Sea Region. Cultures, Politics, Scoietas", ed. Witold Maciejewski, Lars Ryden, Uppsala 2002 : [recenzja] / Jan Szymański.. Acta Poloniae Historica. 69(4). 5 indexed citations

Kjellström, Barbro, Cecilia Linde, Tom Bennett, Åke Ohlsson, & Lars Rydén. (2004). Six Years Follow-Up of an Implanted SvO2 Sensor in the Right Ventricle. European Journal of Heart Failure. 6(5). 627–634. 15 indexed citations

Shelley, Emer & Lars Rydén. (2004). Promoting heart health—a European consensus. European Journal of Cardiovascular Prevention & Rehabilitation. 11(2). 85–86. 3 indexed citations

Ehlers, Mario R., Klas Malmberg, Gunnar Ronquist, et al.. (2003). Glucagon-like peptide-1 (7–36) amide prevents the accumulation of pyruvate and lactate in the ischemic and non-ischemic porcine myocardium. Peptides. 24(4). 569–578. 84 indexed citations

Poole‐Wilson, Philip, Barry F. Uretsky, Kristian Thygesen, et al.. (2002). eHEART: www.heartjnl.com. Heart. 89(1). 48–48. 1 indexed citations

10.

Cleland, John G.F., Paul W. Armstrong, John D. Horowitz, et al.. (1999). Baseline Clinical Characteristics of Patients Recruited into the Assessment of Treatment with Lisinopril and Survival Study. European Journal of Heart Failure. 1(1). 73–79. 16 indexed citations

11.

Rydén, Lars & Anders Hamsten. (1997). The Way Ahead in the Management of Unstable Coronary Artery Disease. The American Journal of Cardiology. 80(5). 64E–67E. 3 indexed citations

12.

Haga, Yoshiyuki, et al.. (1996). Impaired myocardial function following chronic cobalt exposure in an isolated rat heart model. Lund University Publications (Lund University). 13 indexed citations

13.

Olsson, Margareta, Carl‐Johan Dalsgaard, Anders Hægerstrand, et al.. (1994). Accumulation of T lymphocytes and expression of interleukin-2 receptors in nonrheumatic stenotic aortic valves. Journal of the American College of Cardiology. 23(5). 1162–1170. 230 indexed citations

14.

Edman, Peter, Erik Björk, & Lars Rydén. (1992). Microspheres as a nasal delivery system for peptide drugs. Journal of Controlled Release. 21(1-3). 165–172. 72 indexed citations

15.

PEHRSSON, S. KENNETH, et al.. (1991). The effect of chronic cobalt exposure on cardiac function in rats. Lund University Publications (Lund University). 8(4). 195–198. 1 indexed citations

16.

Hatori, Nobuo, Hiroyuki Tadokoro, Kazuhito Satomura, et al.. (1991). Beneficial effects of coronary venous retroinfusion but not left atrial administration of superoxide dismutase on myocardial necrosis in pigs. European Heart Journal. 12(3). 442–450. 12 indexed citations

17.

Rydén, Lars. (1990). Practical biochemistry for colleges. Journal of Biochemical and Biophysical Methods. 21(2). 182–183. 1 indexed citations

18.

Corday, Eliot & Lars Rydén. (1989). Why some physicians have concerns about the cholesterol awareness program. Journal of the American College of Cardiology. 13(2). 497–502. 11 indexed citations

19.

Rydén, Lars, Detlef Gabel, & David Eaker. (1973). A Model Of The Three‐Dimensional Structure Of Snake Venom Neurotoxins Based On Chemical Evidence. International journal of peptide & protein research. 5(4). 261–273. 74 indexed citations

20.

Rydén, Lars. (1971). Evidence for proteolytic fragments in commercial samples of human ceruloplasmin. FEBS Letters. 18(2). 321–325. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact